Bernard Munos is the founder of InnoThink, a consultancy that advises numerous companies and nonprofits on how to become better innovators. He previously served as an advisor for corporate strategy at Eli Lilly and Company. He is a Senior Fellow at FasterCures (Milken Institute), and a member of several advisory bodies at the National Institutes of Health, the Institute of Medicine, and the journal Science Translational Medicine. He received his MBA from Stanford University, and holds other graduate degrees in animal science and economics. He blogs for Forbes Magazine and FasterCures, and has been named one of the 25 most influential people in biopharma.
Alisa Wright is an entrepreneur and founder of BioConvergence, a woman-owned life sciences company that offers development, small-scale production, quality control testing, and supply chain services. She received her BS and MS degrees from Purdue’s schools of pharmacy and engineering and has over 25 years of experience in product development, clinical and commercial manufacturing, product launches, global supply chain, regulatory affairs, quality assurance, and strategic planning. Her previous employers include Eli Lilly and Company, Cook Pharmica, and Baxter International, and she has forged relationships with over 500 life sciences firms. She serves on boards and committees at BioCrossroads, Purdue University’s School of Pharmacy, Indiana University's School of Informatics, YMCA, and Indiana’s Chamber of Commerce.
Timothy Wright is an executive with 40+ years experience in banking, finance, private equity, and civic philanthropy. He has been involved in leading for-profit and not-for-profit institutions and serving on numerous boards, including Ameritrust Indiana Banks, SYM Financial Advisors, Office of Treasurer, State of Indiana, Indiana Bureau of Motor Vehicles, Eiteljorg Museum, Indianapolis Museum of Art, and Butler University. Recently, Tim has focused on private equity company ventures and civic philanthropy.